Related Experiment Videos
[Adrenocortical tumors with neuroendocrine differentiation]
I A Kazantseva1, G A Poliakova, L G Gurevich
1Moscow Region Research Clinical Institute, 129110, Moscow.
Arkhiv Patologii
|February 11, 2003
Summary
Neuroendocrine markers like synaptophysin and chromogranin A are expressed in adrenocortical tumors and pheochromocytomas. Neural differentiation proteins (protein S-100) were also observed in some tumor cells.
Area of Science:
- Endocrinology
- Oncology
- Neuroscience
Background:
- Adrenocortical tumors and pheochromocytomas are neoplasms of the adrenal gland.
- Understanding their cellular origins and differentiation is crucial for diagnosis and treatment.
Observation:
- Immunohistochemical analysis was performed on 18 adrenocortical tumors and 5 pheochromocytomas.
- Ultrastructural examination identified neuroendocrine granules in tumor cells.
Findings:
- Synaptophysin and chromogranin A expression was detected in cortical adenomas, "frontier" neoplasms, and 20-75% of carcinoma cells.
- Protein S-100, a marker of neural differentiation, was observed in some cells of cortico-medullary tumors.
Implications:
- These findings suggest a potential neuroendocrine or neural origin for a subset of adrenal tumors.
- Identifying these markers may aid in classifying adrenal neoplasms and understanding their behavior.
- Further research could explore the clinical significance of these neuroendocrine and neural markers in adrenal tumor management.